PharmaShots | Incisive News in 3 Shots

Subscribe Now

Quince Therapeutics

Quince Therapeutics to Acquire EryDel SpA and P-III Lead Asset EryDex Targeting Ataxia-Telangiectasia

Quince Therapeutics to Acquire EryDel SpA and P-III Lead Asset EryDex Targeting Ataxia-Telangiectasia

July 25, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us